Castle Biosciences Inc.

NASDAQ: CSTL · Real-Time Price · USD
16.23
-0.27 (-1.64%)
At close: May 21, 2025, 11:42 AM

Castle Biosciences Revenue Breakdown

Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Dermatologic Revenue 257M 183.38M 124.81M 85.75M
Dermatologic Revenue Growth +40.15% +46.92% +45.54% n/a

Operating Expense Breakdown

Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018
Selling, General, and Administrative Revenue 58.62M 49.97M 50.5M 50.71M 48.41M 43.77M 44.62M 44.68M 46.76M 38.43M 36.63M 37.5M 30.45M 25.16M 22.59M 20.82M 18.16M 14.96M 11.7M 10.39M 11.08M 9.85M 7.12M 6.82M 6.05M 4.16M 3.92M 4.16M 4.23M
Selling, General, and Administrative Revenue Growth +17.32% -1.06% -0.41% +4.75% +10.59% -1.89% -0.14% -4.45% +21.69% +4.91% -2.33% +23.13% +21.04% +11.35% +8.52% +14.65% +21.41% +27.82% +12.62% -6.19% +12.44% +38.33% +4.41% +12.81% +45.20% +6.28% -5.80% -1.61% n/a
Research and Development Revenue 12.59M 11.68M 12.32M 14.05M 13.46M 12.91M 12.92M 13.31M 14.39M 11.31M 10.91M 11.93M 10.76M 9.45M 7.5M 6.79M 5.91M 4.58M 3.06M 2.7M 2.91M 3.16M 1.51M 1.32M 1.39M 1.14M 1.29M 1.16M 1.26M
Research and Development Revenue Growth +7.80% -5.24% -12.30% +4.43% +4.22% -0.10% -2.89% -7.54% +27.27% +3.69% -8.54% +10.83% +13.93% +25.93% +10.41% +14.98% +28.97% +49.80% +13.09% -7.17% -7.79% +108.52% +15.01% -5.50% +22.48% -12.07% +11.65% -8.20% n/a